| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/17/2007 | EP1743890A1 4,5-Dihydro-1H-pyrazole derivatives, their preparation and use as medicaments |
| 01/17/2007 | EP1743889A1 Sustituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood |
| 01/17/2007 | EP1743888A1 Carbonyl substituted pyrazoline compounds, their preparation and use as CB1 receptor modulators |
| 01/17/2007 | EP1743887A1 Thiocarbonyl-substituted pyrazoline compounds, their preparation and use as CB1 modulators |
| 01/17/2007 | EP1742938A1 Preparation of candesartan cilexetil in high purity |
| 01/17/2007 | EP1742934A2 Piperidine derivatives as modulators of chemokine receptor ccr5 |
| 01/17/2007 | EP1742932A1 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin v1a receptor |
| 01/17/2007 | EP1742913A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 01/17/2007 | EP1742912A1 Novel androgens |
| 01/17/2007 | EP1742907A2 Certain chemical entities, compositions, and methods |
| 01/17/2007 | EP1742905A2 Process of making alfa-aminooxyketone/ alfa-aminooxyaldehyde and alfa-hydroxyketone/ alfa-hydroxyaldehyde compounds and a process of making reaction products from cyclic alfa, beta-unsaturated ketone substrates and nitroso substrates |
| 01/17/2007 | EP1400518B1 Heterocyclic compound derivatives and medicines |
| 01/17/2007 | EP1392309B1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/17/2007 | EP1268444B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/17/2007 | CN1898234A Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 01/17/2007 | CN1898232A Maleate salts of a quinazoline derivative useful as an antiangiogenic agent |
| 01/17/2007 | CN1898216A Amide derivatives |
| 01/17/2007 | CN1898208A Amide derivative and medicine |
| 01/17/2007 | CN1898205A Indolinone derivatives and their use in treating disease-states such as cancer |
| 01/17/2007 | CN1898204A 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
| 01/17/2007 | CN1897937A 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
| 01/17/2007 | CN1897936A Cyclic guanidines, compositions containing such compounds and methods of use |
| 01/17/2007 | CN1896075A Processes for producing indole compound |
| 01/17/2007 | CN1896074A Fluorescent molecular probe and use for inspecting transient metal and heavy metal ion |
| 01/17/2007 | CN1896070A 2- and 2,5-substituted phenylketo-enols |
| 01/17/2007 | CN1896060A Tetrahydro-indolone and tetrahydro-indazolone derivatives and their use |
| 01/17/2007 | CN1295227C Barbituric acid derivs with antimetastatic and antitumor activity |
| 01/17/2007 | CN1295216C Molindone derivatives and use for preparing antineoplastic medicine thereof |
| 01/16/2007 | US7164030 Process |
| 01/16/2007 | US7164029 Process for the preparation of benzylimidazole derivatives |
| 01/16/2007 | US7164016 Complex containing radioactive material; medical diagnosis of tumor |
| 01/16/2007 | US7163995 Low-viscosity polyisocyante composition having high functionality and method for preparing same |
| 01/16/2007 | US7163943 e.g., 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3 ,5]triazine-2,4-diamine; inhibit or block glycated protein produced induction of the signaling-associated inflammatory response in endothelial cells and inhibit smooth muscle proliferation. |
| 01/16/2007 | US7163937 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/11/2007 | WO2007005863A1 Crystalline forms of (2r-trans)-6-chloro-5[[4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-n,n, 1-trimethyl-alpha-oxo-1h-indole-3-acetamide monohydrochloride |
| 01/11/2007 | WO2007005673A1 Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors |
| 01/11/2007 | WO2007005503A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 01/11/2007 | WO2007005455A2 Improved process for preparing (disubstitutedpropenyl) phenylalkyl substituted heterocycles |
| 01/11/2007 | WO2007005454A2 Improved process for preparing insecticidal (disubstitutedpropenyl) phenylalkyl substituted heterocycles |
| 01/11/2007 | WO2007005450A2 Improved process for preparing (disubstitutedpropenyl) phenylalkyl substituted heterocycles |
| 01/11/2007 | WO2007005404A1 AMINO-5-(6-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR ß-SECRETASE MODULATION |
| 01/11/2007 | WO2007005366A1 AMlNO-5-(5-MEMBERED)HETEROARYLIMIDAZOLONE COMPOUNDS AND THE USE THEREOF FOR β-SECRETASE MODULATION |
| 01/11/2007 | WO2007004735A1 Method for producing 4(3h)-quinazolinone derivative |
| 01/11/2007 | WO2007004041A2 New compounds and their pharmaceutical use |
| 01/11/2007 | WO2007003965A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 01/11/2007 | WO2007003604A2 Hists1mine h3 receptor antagonists |
| 01/11/2007 | WO2007003280A1 A process for the preparation of losartan derivatives by chlorination and reduction of the respective 1h-imidazole-5-carbaldehydes |
| 01/11/2007 | WO2007003020A1 Oral formulations comprising ondansetron and a highly dosed sweeten |
| 01/11/2007 | WO2006124780A3 Ih-benzo [d] imidazole compounds as inhibitors of b-raf kinase |
| 01/11/2007 | WO2006118955A3 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles |
| 01/11/2007 | WO2006113498A3 2-amino-quinaz0lin-5-ones as hsp90 inhibitors useful in treating proliferation diseases |
| 01/11/2007 | WO2006094209A3 N-benzimidazolylalkyl-substituted amide sirtuin modulators |
| 01/11/2007 | WO2006009734A8 Gonadotropin releasing hormone receptor antagonists |
| 01/11/2007 | US20070010689 Optically active 3,3'-dithiobis(2-amino-2methylpropionic acid) derivative and process for producing optically active 2-amino-3-mercapto-2-methylpropionic acid derivative |
| 01/11/2007 | US20070010671 Novel quinazoline derivatives and methods of treatment related to the use thereof |
| 01/11/2007 | US20070010668 antineoplastic/antimitotic agents; inhibit proliferation of the cell; breast cancer, colon cancer, lung cancer, prostate cancer, lymphoma, leukemia, endometrial cancer, melanoma; Polo-like kinase inhibitors; 2-({5-nitro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)benzoic acid hydrochloride |
| 01/11/2007 | US20070010663 Dissymmetrical diazo compounds containing having at least one 2-imidazolium unit and a cationic or non-cationic linker, compositions comprising them, method of coloring, and device |
| 01/11/2007 | US20070010569 4-Methyl-5-(2-oxo-1,2-dihydroindol-3- ylidenemethyl)-1H-pyrrole-2- carboxylic acid; cancer |
| 01/11/2007 | US20070010561 Prenylation inhibitors and methods of their synthesis and use |
| 01/11/2007 | US20070010560 Benzimidazole derivatives as raf kinase inhibitors |
| 01/11/2007 | US20070010559 Indole derivatives for use as chemical uncoupler |
| 01/11/2007 | US20070010555 Indazole having analgesic activity |
| 01/11/2007 | US20070010554 Aryl substituted pyridines and the use thereof |
| 01/11/2007 | US20070010540 ;Crystal proteins; antineoplastic agents for colon or breast carcinoma; diamino-pyrimidine Colony stimulating factors (cFMS) inhibitors like 5-{3-methoxy-4-[(4-methoxybenzyl)oxy]benzyl}pyrimidine-2,4-diamine; drug screening |
| 01/11/2007 | US20070010537 Fused pyramidine derivative and use thereof |
| 01/11/2007 | US20070010534 Novel compounds |
| 01/11/2007 | US20070010533 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection |
| 01/11/2007 | US20070010532 3-Pyridylcarboxamide derivatives as pesticidal agents |
| 01/11/2007 | US20070010531 Substituted pyrazole compounds |
| 01/11/2007 | US20070010530 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 01/11/2007 | US20070010529 Nitrogenous heterocyclic compounds and medical use thereof |
| 01/11/2007 | US20070010526 Therapeutic isoquinoline compounds |
| 01/11/2007 | US20070010524 Azaindazole compounds and methods of use |
| 01/11/2007 | US20070010509 Cycloamine ccr5 receptor antagonists |
| 01/11/2007 | US20070010489 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing |
| 01/11/2007 | US20070009980 Continuous fluorogenic analyte assays with dendritic amplification of signal |
| 01/11/2007 | US20070009960 Characterising polypeptides |
| 01/11/2007 | US20070009442 Macrocyclic metal complexes and their use for the production of conjugates with biomolecules |
| 01/11/2007 | CA2614148A1 Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors |
| 01/11/2007 | CA2614138A1 Method for producing 4(3h)-quinazolinone derivative |
| 01/11/2007 | CA2614116A1 Histamine h3 receptor antagonists |
| 01/11/2007 | CA2613435A1 Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for .beta.-secretase modulation |
| 01/11/2007 | CA2613192A1 Histamine h3 receptor agents, preparation and therapeutic uses |
| 01/11/2007 | CA2613045A1 Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for .beta.-secretase modulation |
| 01/11/2007 | CA2611867A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 01/10/2007 | EP1741714A1 Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient |
| 01/10/2007 | EP1741713A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/10/2007 | EP1741711A1 A process for the preparation of losartan derivatives by chlorination and reduction of the respective 1H-imidazole-5-carbaldehydes |
| 01/10/2007 | EP1741703A1 Pyridone derivative |
| 01/10/2007 | EP1741428A2 Cell adhesion inhibitors |
| 01/10/2007 | EP1740578A1 4- 2- (cycloalkylamino) pyrimidin-4-yl ] - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases |
| 01/10/2007 | EP1740577A2 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments |
| 01/10/2007 | EP1740575A2 Pyrrolidine derivatives useful as bace inhibitors |
| 01/10/2007 | EP1740573A1 Amides as bace inhibitors |
| 01/10/2007 | EP1740549A2 Novel imidazoles |
| 01/10/2007 | EP1740538A2 Bicyclic heterocycles useful as serine protease inhibitors |
| 01/10/2007 | EP1740185A1 Benzodiazepines for treating or preventing rsv infection |
| 01/10/2007 | EP1353905B1 Piperidine/piperazine-type inhibitors of p38 kinase |
| 01/10/2007 | EP1109803B1 Substituted imidazoles having cytokine inhibitory activity |
| 01/10/2007 | EP0821585B1 Use of alpha 1l-agonists in the treatment of urinary incontinence |